The cumulative risk of lung cancer among current, ex- and never-smokers in European men

被引:0
作者
A Crispo
P Brennan
K-H Jöckel
A Schaffrath-Rosario
H-E Wichmann
F Nyberg
L Simonato
F Merletti
F Forastiere
P Boffetta
S Darby
机构
[1] Epidemiology Unit,Department of Environmental Medicine and Public Health
[2] National Cancer Institute,Department of Epidemiology
[3] International Agency for Research on Cancer,undefined
[4] Institute for Medical Informatics,undefined
[5] Biometry and Epidemiology,undefined
[6] Institute of Epidemiology,undefined
[7] GSF National Research Center,undefined
[8] Institute of Environmental Medicine,undefined
[9] Karolinska Institute,undefined
[10] University of Padova,undefined
[11] Unit of Cancer Epidemiology,undefined
[12] CeRMS and Centre for Oncologic Prevention,undefined
[13] University of Turin,undefined
[14] Rome E Health Authority,undefined
[15] Clinical Trials Service Unit (CTSU),undefined
[16] Radcliffe Infirmary,undefined
来源
British Journal of Cancer | 2004年 / 91卷
关键词
lung cancer; cigarette smoking;
D O I
暂无
中图分类号
学科分类号
摘要
Recent analyses based on UK data indicate that people who stop smoking, even well into middle age, avoid most of their subsequent risk of lung cancer. We investigated whether similar absolute risks of lung cancer in men are found in other European countries with different smoking patterns and at different stages of their lung cancer epidemic. Using data for men from a multicentre case–control study of lung cancer in the UK, Germany, Italy and Sweden, and including 6523 lung cancer cases and 9468 controls, we combined odds ratio estimates with estimates of national lung cancer incidence rates to calculate the cumulative risk of lung cancer among men by age 75. Lung cancer cumulative risks by age 75 among continuing smokers were similar for the UK, Germany and Italy at 15.7, 14.3 and 13.8% respectively, whereas the cumulative risk among Swedish male smokers was 6.6%. The proportion of the risk of lung cancer avoided by quitting smoking before the age of 40 was comparable between the four countries, at 80% in Italy and 91% in the UK, Germany and Sweden. Similarly, the proportion of the excess risk avoided by quitting before the age of 50 ranged from 57% in Italy to 69% in Germany. Our results support the important conclusion that for long-term smokers, giving up smoking in middle age avoids most of the subsequent risk of lung cancer, and that lung cancer mortality in European men over the next three decades will be determined by the extent to which current smokers can successfully quit smoking.
引用
收藏
页码:1280 / 1286
页数:6
相关论文
共 50 条
  • [41] Alpha-1 antitrypsin deficiency and risk of lung cancer in never-smokers: a multicentre case–control study
    Ramón Antonio Tubío-Pérez
    María Torres-Durán
    María Esmeralda García-Rodríguez
    Cristina Candal-Pedreira
    Julia Rey-Brandariz
    Mónica Pérez-Ríos
    Juan Barros-Dios
    Alberto Fernández-Villar
    Alberto Ruano-Raviña
    BMC Cancer, 22
  • [42] Alpha-1 Antitrypsin Deficiency and Lung Cancer Risk A Case-Control Study in Never-Smokers
    Torres-Duran, Maria
    Ruano-Ravina, Alberto
    Parente-Lamelas, Isaura
    Abal-Arca, Jose
    Leiro-Fernandez, Virginia
    Montero-Martinez, Carmen
    Pena, Carolina
    Castro-Anon, Olalla
    Golpe-Gomez, Antonio
    Gonzalez-Barcala, Francisco J.
    Martinez, Cristina
    Guzman-Taveras, Rosirys
    Provencio, Mariano
    Jose Mejuto-Marti, Maria
    Fernandez-Villar, Alberto
    Miguel Barros-Dios, Juan
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : 1279 - 1284
  • [43] Lung cancer survival in never-smokers and exposure to residential radon: Results of the LCRINS study
    Casal-Mourino, Ana
    Ruano-Ravina, Alberto
    Torres-Duran, Maria
    Parente-Lamelas, Isaura
    Provencio-Pulla, Mariano
    Castro-Anon, Olalla
    Vidal-Garcia, Iria
    Pena-Alvarez, Carolina
    Abal-Arca, Jose
    Pineiro-Lamas, Maria
    Fuente-Merino, Ismael
    Fernandez-Villar, Alberto
    Abdulkader, Ihab
    Valdes-Cuadrado, Luis
    Miguel Barros-Dios, Juan
    Perez-Rios, Monica
    CANCER LETTERS, 2020, 487 : 21 - 26
  • [44] Lung Cancer in Never-Smokers: A Multicenter Case-Control Study in North China
    Liang, Di
    Wang, Jingxi
    Li, Daojuan
    Shi, Jin
    Jing, Jin
    Shan, Baoen
    He, Yutong
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [45] Exposure to Residential Radon and Lung Cancer in Never-Smokers: the Preliminary Results of the LCRINS Study
    Ruano-Ravina, Alberto
    Prini-Guadalupe, Luciana
    Miguel Barros-Dios, Juan
    Abal-Arca, Jose
    Leiro-Fernandez, Virginia
    Isabel Gonzalez-Silva, Ana
    Golpe-Gomez, Antonio
    Javier Gonzalez-Barcala, Francisco
    Pena, Carolina
    Montero-Martinez, Carmen
    Martinez-Gonzalez, Cristina
    Jose Mejuto-Marti, Maria
    Veres-Racamonde, Alejandro
    ARCHIVOS DE BRONCONEUMOLOGIA, 2012, 48 (11): : 405 - 409
  • [46] Alcohol consumption and lung cancer risk in never smokers
    Antonio Garcia-Lavandeira, Jose
    Ruano-Ravina, Alberto
    Miguel Barros-Dios, Juan
    GACETA SANITARIA, 2016, 30 (04) : 311 - 317
  • [47] Alpha-1 antitrypsin deficiency and risk of lung cancer in never-smokers: a multicentre case-control study
    Antonio Tubio-Perez, Ramon
    Torres-Duran, Maria
    Esmeralda Garcia-Rodriguez, Maria
    Candal-Pedreira, Cristina
    Rey-Brandariz, Julia
    Perez-Rios, Monica
    Barros-Dios, Juan
    Fernandez-Villar, Alberto
    Ruano-Ravina, Alberto
    BMC CANCER, 2022, 22 (01)
  • [48] Reproductive factors and risk of lung cancer among 300,000 Chinese female never-smokers: evidence from the China Kadoorie Biobank study
    Elbasheer, Marwa M. A.
    Bohrmann, Bastian
    Chen, Yiping
    Lv, Jun
    Sun, Dianjianyi
    Wu, Xia
    Yang, Xiaoming
    Avery, Daniel
    Li, Liming
    Chen, Zhengming
    Kartsonaki, Christiana
    Chan, Ka Hung
    Yang, Ling
    BMC CANCER, 2024, 24 (01)
  • [49] Lung Cancer Risk in Never-Smokers of European Descent is Associated With Genetic Variation in the 5p15.33 TERT-CLPTM1Ll Region
    Hung, Rayjean J.
    Spitz, Margaret R.
    Houlston, Richard S.
    Schwartz, Ann G.
    Field, John K.
    Ying, Jun
    Li, Yafang
    Han, Younghun
    Ji, Xuemei
    Chen, Wei
    Wu, Xifeng
    Gorlov, Ivan P.
    Na, Jie
    de Andrade, Mariza
    Liu, Geoffrey
    Brhane, Yonathan
    Diao, Nancy
    Wenzlaff, Angela
    Davies, Michael P. A.
    Liloglou, Triantafillos
    Timofeeva, Maria
    Muley, Thomas
    Rennert, Hedy
    Saliba, Walid
    Ryan, Brid M.
    Bowman, Elise
    Barros-Dios, Juan-Miguel
    Perez-Rios, Monica
    Morgenstern, Hal
    Zienolddiny, Shanbeh
    Skaug, Vidar
    Ugolini, Donatella
    Bonassi, Stefano
    van der Heijden, Erik H. F. M.
    Tardon, Adonina
    Bojesen, Stig E.
    Landi, Maria Teresa
    Johansson, Mattias
    Bickeboeller, Heike
    Arnold, Susanne
    Le Marchand, Loic
    Melander, Olle
    Andrew, Angeline
    Grankvist, Kjell
    Caporaso, Neil
    Teare, M. Dawn
    Schabath, Matthew B.
    Aldrich, Melinda C.
    Kiemeney, Lambertus A.
    Wichmann, H-Erich
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (08) : 1360 - 1369
  • [50] Molecular analysis of human papillomavirus in never-smokers with non-small cell lung cancer
    Isa, Shun-Ichi
    Kurahara, Yu
    Yamamoto, Satomi
    Tamiya, Akihiro
    Omachi, Naoki
    Asami, Kazuhiro
    Okishio, Kyoichi
    Utsumi, Tomoki
    Ito, Norimasa
    Yoon, Hyung-Eun
    Matsumura, Akihide
    Atagi, Shinji
    Kawaguchi, Tomoya
    ONCOLOGY LETTERS, 2015, 9 (02) : 927 - 929